Company intelligence / Profile preview

Venova Technologies

Cambridge, Massachusetts, United Statesvenovatechnologies.com ↗

Ownership: Private
Development stage: Other

Overview

Venova Technologies has developed a prototype for a long-lasting, hormone-free, copper-free female contraceptive device. The company has received multiple NIH SBIR grants and innovation awards but has not yet reported clinical trial results. Their solution aims to provide effective contraception without the side effects associated with hormonal or copper-based methods. No published human clinical data as of June 2025.

Therapeutic areas: Women's Health
Modalities: Device (non-hormonal contraceptive device)
Industry: Implantable Medical Devices

Partnerships

Supported by HealthTech Capital Readiness Program and LabCentral Ignite mentorship programs; no major pharma partnerships disclosed as of June 2025.

Beyond the preview

Go deeper on Venova Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Venova Technologies.

Explore the full profile